Activation of the murine c-myc promoter by murine c-Myb protein was ex
amined in several cell lines by using a transient expression system in
which Myb expression vectors activate the c-myc promoter linked to a
chloramphenicol acetyltransferase reporter gene or a genomic beta-glob
in gene. Sl nuclease protection analyses confirmed that the induction
of c-myc by c-Myb was transcriptional and affected both P1 and P2 star
t sites in a murine T-cell line, EL4, and a myelomonocytic line, WEHI-
3. Mutational analyses of the c-myc promoter revealed that two distinc
t regions could confer Myb responsiveness in two T-cell lines, a dista
l site upstream of P1 and a proximal site within the first noncoding e
xon. In contrast, only the proximal site was required for other cell l
ineages examined. Five separate Myb-binding sites were located in this
proximal site and found to be important for c-Myb trans activation. D
NA binding was necessary for c-myc activation, as shown by the loss of
function associated with mutation of Myb's DNA-binding domain and by
trans-dominant repressor activity of the DNA binding, trans-activation
-defective mutant. The involvement of additional protein factors was a
ddressed by inhibiting protein synthesis with cycloheximide in a condi
tional expression system in which the activity of presynthesized Myb w
as under the control of estrogen. These experiments indicate that de n
ovo synthesis of additional proteins was not necessary for c-myc trans
activation. Together these data reveal two cell lineage-dependent pat
hways by which c-Myb regulates c-myc; however, both pathways are mecha
nistically indistinguishable in that direct DNA binding by Myb is requ
ired for activating c-myc whereas neither de novo protein synthesis no
r other labile proteins are necessary.